Omniscient and the Jacobs Institute launch Connectomics Innovation Program 

Omniscient and The Jacobs Institute, Inc. have launched a strategic partnership to bring connectomics into real-world clinical practice. A move that could fundamentally change how we understand and treat brain disorders. At the heart of this collaboration is the Connectomics Innovation Program—an ambitious initiative that blends research, clinical care, and education to reshape the role of brain network science in medicine. 

For those unfamiliar with the term, connectomics refers to the mapping and study of the brain’s complex networks, how different regions interact to power thought, movement, memory, language, and emotion. When those connections break down due to stroke, injury, or disease, the consequences can be devastating. Connectomics offers a new way of seeing these disruptions, not just as isolated events, but as network-level failures that can be better understood, predicted, and treated. 

“Connectomics is the future of brain care, and Omniscient is the only company bringing this vision to life at scale,” said Arie Henkin, Chief Clinical Officer at Omniscient. “This partnership allows us to accelerate the clinical translation of brain network data and fundamentally reshape how we diagnose, treat, and understand neurological disease.” 

Also read: FDA Clears Methinks AI to Transform Stroke Triage with Standard CT Scans 

The Jacobs Institute, uniquely positioned between a major neurovascular hospital and a research university, offers an ideal environment for this kind of cross-disciplinary collaboration. The partnership is focused on applying Omniscient’s advanced, AI-powered connectomic tools to some of neurology’s most pressing challenges. 

Tackling stroke, coma, and neurologic deficits through brain networks 

At its core, the Connectomics Innovation Program will drive research across three high-impact areas: 

• Stroke: Mapping brain networks to better predict recovery and tailor rehabilitation strategies. 

• Coma and disorders of consciousness: Identifying brain network signatures that can provide more accurate prognoses. 

• Neurologic deficits: Linking specific impairments in movement, memory, speech, or behaviour to underlying network disruptions. 

These studies are powered by Omniscient’s proprietary tools, including Quicktome®, the first and only FDA-cleared platform for clinical connectomic analysis. 

“This isn’t just about research, it’s about changing how we care for patients,” said Dr. Adnan Siddiqui, CEO and CMO of The Jacobs Institute, Inc. “With Omniscient, we’re building a program that can turn cutting-edge science into better outcomes for real people.” 

More Than a Research Project 

What makes this partnership especially noteworthy is its focus on translation. The program is built to ensure that discoveries don’t just sit in academic journals, they’re designed to inform treatment protocols, guide surgical planning, and equip the next generation of clinicians. 

As part of the initiative, both organizations will collaborate on developing educational programs to train specialists in connectomic principles. The Jacobs Institute is set to become a global hub for this new field, bringing in experts from medicine, engineering, and technology to collaborate on next-generation brain care. 

The launch of this partnership is also a clear signal that connectomics is maturing, moving from a promising research concept to a practical tool in clinical medicine. With Omniscient’s technological expertise and The Jacobs Institute’s unique position at the crossroads of academia and care delivery, the Connectomics Innovation Program is set to lay the groundwork for what could be a new era in neurological care. 

Curious about where Connectomics fits into the broader MedTech conversation?  

Join us at MedTech Malta 2025, where global leaders in brain science, AI, and clinical innovation come together to exchange ideas, challenge norms, and share progress. 

Whether you’re looking to take the stage as a speaker, showcase your innovation in the Startup Pitch Competition, or celebrate excellence at the MedTech World Awards Gala, the event offers countless ways to get involved and make meaningful connections. 

Secure your spot now. 

For more information, connect with us at [email protected]